Viewing Study NCT00451295


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2026-01-29 @ 8:05 PM
Study NCT ID: NCT00451295
Status: TERMINATED
Last Update Posted: 2011-11-15
First Post: 2007-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
None Dialysis View
None Hyperphosphatemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Kidney Disease View
None Dialysis View
None Hyperphosphatemia View